Biohaven Ownership | Who Owns Biohaven?
Biohaven Ownership Summary
Biohaven is owned by 81.59% institutional investors, 9.21% insiders, and 9.20% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.69% of BHVN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Biohaven shares.
BHVN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Biohaven | 81.59% | 9.21% | 9.20% |
| Sector | Healthcare Stocks | 42.52% | 10.82% | 46.66% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 7.87M | 7.69% | $118.20M |
| Blackrock | 6.17M | 7.56% | $214.15M |
| Janus henderson group | 6.98M | 7.40% | $260.73M |
| Stifel financial | 6.61M | 6.46% | $99.24M |
| Suvretta capital management | 5.62M | 5.49% | $84.36M |
| State street | 4.26M | 4.16% | $63.92M |
| Rp management | 2.94M | 3.11% | $146.74M |
| Vanguard group | 2.88M | 2.81% | $43.16M |
| Bellevue group | 2.80M | 2.74% | $42.07M |
| Fmr | 2.43M | 2.37% | $36.43M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 2.94M | 64.43% | $146.74M |
| Oracle investment management | 673.17K | 6.51% | $9.50M |
| Infinitum asset management | 1.70M | 4.69% | $25.52M |
| Stempoint capital lp | 1.02M | 3.06% | $15.27M |
| Bison wealth | 332.43K | 2.74% | $12.42M |
| 5am venture management | 478.97K | 2.63% | $7.19M |
| Qtr family wealth | 332.29K | 2.37% | $4.99M |
| Suvretta capital management | 5.62M | 2.16% | $84.36M |
| Prosight management, lp | 600.00K | 2.10% | $9.01M |
| Lion point capital, lp | 22.70K | 1.94% | $340.73K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Infinitum asset management | 1.70M | 4.69% | 1.15M |
| Qube research | 1.27M | 0.02% | 1.13M |
| Norges bank | 902.57K | 0.00% | 902.57K |
| Millennium management | 901.26K | 0.01% | 895.46K |
| Stempoint capital lp | 1.02M | 3.06% | 842.56K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 2.88M | 0.00% | -6.37M |
| Farallon capital management | - | - | -4.81M |
| Armistice capital | - | - | -2.14M |
| Perceptive advisors | - | - | -1.49M |
| Darwin global management | - | - | -1.48M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 902.57K | 0.00% | 902.57K | $33.71M |
| Artal group | 306.70K | 0.27% | 306.70K | $10.65M |
| Weiss asset management lp | 242.12K | 0.04% | 242.12K | $3.63M |
| Squarepoint ops | 241.42K | 0.00% | 241.42K | $3.62M |
| Point72 asset management | 81.00K | 0.00% | 81.00K | $1.22M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Beacon capital management | -1.00 |
| Allspring global investments | -2.00 |
| Gps wealth strategies group | -5.00 |
| Fortitude family office | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 286 | 10.00% | 83,525,986 | -0.78% | 81 | 1.21% | 132 | -2.94% | 74 | 10.45% |
| Jun 30, 2025 | 268 | -3.60% | 86,968,877 | -2.99% | 84 | 1.10% | 138 | -2.82% | 70 | -9.09% |
| Mar 31, 2025 | 20 | -92.51% | 4,003,493 | -95.66% | 3 | 0.04% | 9 | -94.12% | 7 | -89.23% |
| Dec 31, 2024 | 107 | -59.62% | 28,793,137 | -66.29% | 30 | 0.37% | 63 | -53.33% | 20 | -73.68% |
| Sep 30, 2024 | 263 | 11.91% | 85,395,678 | 3.25% | 90 | 1.02% | 133 | -5.00% | 76 | 43.40% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.83M | 2.68% | -62.83K |
| Vanguard US Total Market Shares ETF | 2.43M | 2.38% | 217.08K |
| iShares Russell 2000 ETF | 2.18M | 2.06% | - |
| BB Biotech AG Ord | 2.04M | 2.02% | - |
| Vanguard Small Cap Index | 2.11M | 1.99% | -14.23K |
| SPDR® S&P Biotech ETF | 1.48M | 1.40% | 3.29K |
| Vanguard Small Cap Value Index Inv | 1.36M | 1.29% | 6.87K |
| T. Rowe Price Health Sciences | 1.28M | 1.21% | -430.46K |
| HBM Healthcare Investments AG Ord | 1.13M | 1.11% | 130.00K |
| Fidelity Select Biotechnology | 1.03M | 0.97% | -15.80K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 17, 2025 | Clark George C. | VP, Chief Accounting Officer | Buy | $144.77K |
| Nov 13, 2025 | Bailey Gregory | - | Buy | $3.00M |
| Nov 13, 2025 | CHILDS JOHN W | - | Buy | $25.00M |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer | Buy | $2.50M |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer | Buy | $2.50M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 5 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 4 | - |
| 2024 Q4 | 3 | - |
| 2024 Q3 | 2 | - |
BHVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools